abstract |
FIELD: medicine. n SUBSTANCE: invention represents an IL-17-binding antibody or its active fragment. What is also presented is a DNA design coding the antibody, a method of producing the antibody, using the antibody, a pharmaceutical composition, an expression vector. n EFFECT: invention can be effectively used for preparing a drug for treating an IL-17 mediated disease or disorder. n 14 cl, 2 dwg, 12 tbl, 4 ex |